Browse the evidence

Long-term adherence to low-carbohydrate diets is associated with a significantly higher risk of all-cause mortality compared to high-carbohydrate diets.

If you are following a low-carbohydrate diet, be aware that current observational evidence suggests it may increase your risk of dying from any cause compared to diets higher in carbohydrates. This risk appears to be driven by the source of nutrients (e.g., animal proteins and fats vs. plant sources). Consider reviewing your diet's composition and consulting a healthcare provider to balance short-term metabolic benefits with long-term survival data.

Low-carbohydrate diets are not significantly associated with an increased risk of cardiovascular disease (CVD) mortality or incidence in the long term.

You do not need to worry that a low-carbohydrate diet will significantly increase your risk of heart disease or stroke based on current observational data. However, the source of your protein and fat (plant vs. animal) may influence these outcomes, so prioritize plant-based sources.

Dietary fish oil (n-3 fatty acids) preserves hepatic insulin sensitivity in high-fat diet-fed wild-type mice by activating PPAR-α, which reduces hepatic diacylglycerol levels; this protective effect is abolished in PPAR-α null mice, demonstrating PPAR-α dependence.

Fish oil supplementation may help maintain liver sensitivity to insulin when consuming a high-fat diet, but this benefit relies on having functional PPAR-α. The mechanism involves reducing specific lipid signals (diacylglycerol) rather than just lowering total liver fat. For humans, this suggests fish oil is a supportive tool for metabolic health, particularly if you have high fat intake, but it is not a standalone cure for insulin resistance.

Supplements containing concentrated Chinese green tea extract (Camellia sinensis) can cause severe, symptomatic hepatotoxicity, including acute liver injury with jaundice and markedly elevated transaminases, which resolves upon discontinuation.

If you are taking a weight-loss supplement containing concentrated green tea extract (Camellia sinensis), be aware of the risk of liver injury. Symptoms include abdominal pain, nausea, jaundice (yellowing of skin/eyes), and dark urine. Stop taking the supplement immediately if these symptoms occur and seek medical attention. Do not assume 'natural' means safe, especially with concentrated extracts.

Metformin reduces hepatocyte triglyceride accumulation and plasma triglycerides in NAFLD patients by inhibiting ApoA5 synthesis via the AMPK/LXRα signaling pathway.

For those with fatty liver, metformin may help reduce liver fat by blocking specific proteins (ApoA5) that store fat in the liver. However, it is not currently a recommended or proven standalone treatment for NAFLD in clinical guidelines, so lifestyle changes remain the primary intervention.

Metformin protects against cardiac ischemia-reperfusion injury and improves heart failure outcomes post-MI by activating AMPK, which promotes glycolysis and prevents mitochondrial permeability transition pore (mPTP) opening.

If you have had a heart attack, metformin (even in low doses) may help protect your heart muscle from further damage by improving energy use in heart cells. This benefit extends to non-diabetic heart failure patients as well, improving heart pumping function.

A higher Oxidative Balance Score (OBS), reflecting a predominance of antioxidant exposures over prooxidants in diet and lifestyle, is positively associated with longer leukocyte telomere length (LTL) in adult females.

For women, maintaining a diet and lifestyle that favors antioxidants over prooxidants is associated with longer telomeres, a marker of cellular aging. This involves consuming foods rich in antioxidants (like fruits, vegetables, whole grains) while minimizing prooxidant stressors like smoking, excessive alcohol, and high processed meat intake. While this study is observational, it suggests that holistic dietary patterns matter more than isolated supplements for preserving cellular longevity.

Fermentable dietary fiber (e.g., guar gum) increases body weight and fat mass in high-fat diet-fed mice compared to non-fermentable fiber (e.g., oat fiber) due to increased energy extraction via short-chain fatty acid (SCFA) production.

If you are trying to lose weight, not all fiber is equal. Fermentable fibers (like guar gum) are broken down into energy (SCFAs) by your gut bacteria, which can add calories and potentially promote weight gain, especially if your diet is high in fat. Non-fermentable fibers (like insoluble oat fiber) are less likely to contribute extra energy and may be more effective for weight management in high-fat diets.

Aberrant protein posttranslational modifications (PTMs) are central drivers of metabolic diseases including diabetes, obesity, and atherosclerosis, and targeting these modifications offers a viable therapeutic strategy.

Metabolic diseases are driven by complex molecular switches (PTMs) that regulate how your body processes energy. While lifestyle changes are the first line of defense, pharmaceutical interventions targeting these specific molecular pathways (like kinase inhibitors) are increasingly available and effective for managing conditions like diabetes and fatty liver disease when lifestyle changes are insufficient.

Substituting protease inhibitors with other antiretroviral drugs (such as nevirapine) can mitigate metabolic abnormalities like dyslipidemia and glucose intolerance, though reversal of fat redistribution is uncertain.

If you develop metabolic issues on your current HIV meds, ask your doctor about switching to a non-PI regimen (like nevirapine). This may fix your cholesterol and blood sugar problems without necessarily reversing the body shape changes, and it can still keep the virus suppressed.

Increasing dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) down-regulates the metabolic conversion of alpha-linolenic acid (ALNA) to longer-chain metabolites (EPA and DPA) in older men, whereas increasing ALNA intake does not up-regulate this conversion.

If you are trying to increase your long-chain omega-3s (EPA/DHA) by eating more plant-based sources (like flax or walnuts), understand that your body's conversion rate is very low and fixed. Increasing your intake of these plant fats will not significantly boost your EPA/DHA levels because your body does not up-regulate the conversion process. To effectively raise EPA/DHA, you must consume pre-formed sources (fatty fish or supplements), which may actually further suppress any minimal conversion from plant sources.

Increasing dietary EPA and DHA intake significantly reduces the metabolic conversion of alpha-linolenic acid (ALNA) to EPA and DPA in older men, demonstrating feedback inhibition of the desaturation/elongation pathway.

If you consume both plant-based omega-3s (ALNA) and fish oil (EPA/DHA), be aware that the fish oil will suppress your body's ability to convert the plant fats into long-chain omega-3s. Since the conversion rate is already very low, this suppression is likely negligible for your overall EPA/DHA levels, but it confirms that plant fats are not an efficient source of long-chain omega-3s when pre-formed sources are available.

Exogenous administration of spermidine or spermine improves glucose homeostasis, insulin sensitivity, and reduces adiposity in diet-induced obesity mouse models.

Current research indicates that spermidine and spermine supplementation may improve metabolic health in obese individuals, particularly by enhancing insulin sensitivity and reducing fat accumulation. However, most evidence comes from animal models. While human trials show increased blood levels with supplementation, direct metabolic benefits in humans are not yet fully established. Consult a healthcare provider before starting supplementation, especially if you have existing metabolic conditions.

Agmatine, a polyamine-related compound produced by gut bacteria and plants, reduces body weight gain, fat depots, and atherosclerotic lesions in high-fat diet-fed animal models.

Agmatine, found in plants and produced by gut bacteria, shows promise in animal studies for reducing fat accumulation and atherosclerosis in obese models. However, specific dosing and human efficacy are not established in this review. It is not currently a standard clinical recommendation for weight loss.

Consumption of cooked, high-starch plant foods (specifically underground storage organs) was an essential evolutionary driver for the expansion of the human brain and body size during the Pleistocene by providing the preformed glucose required for high-energy tissues.

While modern humans do not need to eat like Pleistocene hominins, this research highlights that digestible carbohydrates, particularly from starchy plants, are a natural and efficient fuel source for the brain. Cooking increases the bioavailability of these carbohydrates, suggesting that processed, low-fiber, or raw starches may not provide the same evolutionary or metabolic benefits as whole, cooked starchy foods.

High copy number variation (CNV) of the salivary amylase gene (AMY1) in humans is an evolutionary adaptation to a starch-rich diet, particularly following the widespread adoption of cooking.

Humans have genetically adapted to digest starch efficiently, especially when cooked. This suggests that starch is a natural part of the human diet, and individuals may have varying capacities to digest it based on their genetics.

Glutamine supplementation promotes M2 macrophage polarization via the glutamine-UDP-GlcNAc pathway and alpha-ketoglutarate production, which may help prevent obesity- or diabetes-associated pathology.

While glutamine is known to support immune health, this review highlights its specific role in shifting immune cells away from inflammation in obesity. Current research is mostly in mice, so humans should consult a doctor before using glutamine specifically for metabolic health, as the direct benefits in people are not yet fully proven.

Succinate accumulation, derived from glutamine-dependent anerplerosis, promotes M1 macrophage polarization and stabilizes HIF-1α, contributing to inflammation in obesity.

High levels of succinate are linked to inflammation in obesity. While you cannot directly 'take' succinate to fix this, understanding that it drives inflammation highlights why managing metabolic health is crucial. No specific succinate-based therapy is currently recommended for humans.

Continuous Positive Airway Pressure (CPAP) treatment for OSA does not consistently improve glucose metabolism (HbA1c or insulin sensitivity) in randomized controlled trials, particularly when adherence is low or treatment duration is short.

CPAP is not a magic bullet for blood sugar control. Its benefits for glucose metabolism are inconsistent and often depend on how many hours you actually use it each night. If you are prescribed CPAP, focus on maximizing your nightly usage time, as higher adherence is linked to better metabolic outcomes.

Small-molecule ago-allosteric modulators of the GLP-1 receptor stimulate glucose-dependent insulin secretion and potentiate endogenous GLP-1 effects without altering GLP-1 potency, offering a potential pathway for orally active diabetes treatments.

This research describes a new class of small molecules that activate the GLP-1 receptor. Currently, these are experimental compounds tested in lab settings (cells and animal tissues). They stimulate insulin release in a glucose-dependent manner, similar to the natural hormone GLP-1, but via a different binding mechanism (allosteric). This is a foundational discovery for developing oral diabetes medications, but no such drug is currently available for human use based on this text.

Engagement with 'fitspiration' social media content is associated with high levels of psychological distress, disordered eating risk, and compulsive exercise behaviors, despite users perceiving positive motivational benefits.

If you follow fitness influencers, be aware that while it may motivate you to exercise, it is also strongly linked to psychological distress and disordered eating patterns. Prioritize content from qualified experts or relatable 'everyday' people who discuss challenges honestly, rather than those promoting unattainable aesthetic ideals. Monitor your mental health and eating habits closely if you feel pressure to achieve a specific look.

Effective obesity prevention and treatment require a multi-sectoral approach involving education, behavior change, political support, and community participation, rather than solely individual-level interventions.

Public health initiatives should focus on policy changes (food labeling, trade policies), community education, and creating safe environments for physical activity, rather than just telling individuals to 'eat less and move more'.

Activation of Sirt1 via exercise or Sirt1-activating compounds (e.g., resveratrol, SRT3025) delays vascular aging and reduces atherosclerosis by enhancing antioxidant enzyme activity and improving endothelial nitric oxide synthase (eNOS) function.

Engage in regular physical exercise, which naturally boosts Sirt1 activity by increasing NAD+ levels. This helps maintain vascular health and may delay age-related cardiovascular decline. While supplements like resveratrol are marketed for this purpose, human evidence is inconsistent, making exercise the most reliable intervention.

Genetic deletion or silencing of the adaptor protein p66Shc reduces oxidative stress, improves endothelial function, and reduces stroke size in animal models, but may increase infarct size in specific myocardial ischemia-reperfusion contexts.

Current research suggests that targeting p66Shc could help prevent stroke and vascular aging, but it is not yet a viable therapeutic strategy due to conflicting effects on heart tissue. Focus on proven lifestyle factors like exercise and diet to manage oxidative stress.